RT Journal Article
SR Electronic
T1 Iopamidol and metrizamide in cervical myelography: side effects, EEG, and CSF changes.
JF American Journal of Neuroradiology
JO Am. J. Neuroradiol.
FD American Society of Neuroradiology
SP 848
OP 850
VO 4
IS 3
A1 L Moschini
A1 O Manara
A1 G Bonaldi
A1 V Cassinari
A1 N Quilici
A1 G Belloni
YR 1983
UL http://www.ajnr.org/content/4/3/848.abstract
AB Two nonionic contrast media, iopamidol and metrizamide (Amipaque), were used for cervical myelography (C1-C2 puncture) in 95 consecutive patients. Both contrast media gave excellent radiographic results. Headache and vagal symptoms were similar in both groups, whereas metrizamide produced more electroencephalographic changes and epileptic seizures. Meningeal irritation occurred in both groups and was severe in three cases. Cerebrospinal fluid showed protein and cellular changes of inflammatory type in both groups. Iopamidol is considered to be the more suitable contrast medium for cervical myelography despite its slight neurotoxicity.